Introduction
============

Conventional smear (CS) using fine-needle aspiration cytology (FNAC) has been well established during the last few decades as the diagnostic test of choice for making initial diagnosis and treatment plans for thyroid lesions ([@bib1]). It has been widely accepted as a primary diagnostic tool owing to its simplicity, safety, possibility of repetition and cost-effectiveness. The major technical limitations in this test are those that occur during the smearing procedure: first, blood-obscuring background generated by abundant vasculature of thyroid lesions; second, poor cellularity due to extensive fibrosis or the cystic nature of the lesion itself; and third, person-to-person variation in the smearing technique often leading to dry artifacts. These problems result in a number of inadequate samples for making a proper diagnosis and cause a decrease in overall efficacy. In fact, many studies have reported a quite high rate of inadequate samples in thyroid FNAC using CS, up to 50.5% ([@bib2]). Therefore, such limitations derived from the nature of the thyroid lesions and the essential parts of the procedure that involve various medical personnel have been a major hindrance to overcome.

Liquid-based preparation (LBP), or thin-layer preparation, was first introduced for gynecologic cervical smears that have similar limitations. Two major systems approved by the United States Food and Drug Administration, ThinPrep (Hologic, Marlborough, MA, USA) and SurePath (BD Diagnostics-TriPath Imaging, Burlington, NC, USA), are basically designed to reduce such variations and artifacts and are intended to produce representative, standardized smears by an automated process. Both techniques consist of collection of the aspirates in specially developed liquid fixative; followed by removal of cell debris, red blood cells and inflammatory cells; homogenization by vortexing and finally a sampling and slideproducing step either by vacuum application or a sedimentation method.

Over 25 years of wide spread use, the diagnostic utility of LBP in gynecologic samples has been relatively well-verified, clarifying its strong and weak points. It provides standardized slides of homogenous cellular smears with well-preserved cell morphology resulting in clearer visualization, shorter interpretation time and more reproducible results among various cytotechnicians and pathologists. In particular, dispersing cell clusters into single cells during the homogenizing step in LBP is an important strong point for gynecologic samples in which cell overlapping is a major hindrance for accurate interpretation.

In terms of application to thyroid FNAC samples, however, where the shapes of cell clusters and the nature of the background are valuable for accurate diagnosis, conflicting results on the diagnostic utility of LBP have been reported. These might be attributable to the diversity of the subject population, subtle differences in detailed procedures and the infancy of application of this technology in this specialized field.

However, many studies have been designed and conducted under pressure to some extent to favor a certain LBP product, potentially leading to biased results, and this should not be neglected. For example, many studies applied different interpretation criteria for sensitivity and specificity that were favorable for their preferred conclusion. Although many investigators now agree that application of LBP to thyroid FNACs is acceptable, to what extent we can trust the results of LBP, whether it is okay to use LBP alone or whether LBP should be applied in combination with CS are aspects that are not clear.

In this study, we performed a systematic review and meta-analysis of the comparative studies of LBP and CS, mainly on ThinPrep and SurePath methods, conducted in thyroid FNACs to draw less biased results and a statistically convincing conclusion on the diagnostic accuracy and utility of LBP in thyroid FNACs.

Subjects and methods
====================

Subjects
--------

This study was approved by the Institutional Review Board of The Catholic University of Korea, College of Medicine (SC15OISbib4). We searched major electronic databases from January 1, 1990 to January 5, 2015 for relevant articles published in medical journals with abstracts written in English. Included databases were MEDLINE (PubMed), Cochrane Library, EMBASE and Google Scholar. There were 7 LBP methods included in the search: ThinPrep, SurePath (also known as AutoCyte PREP), Liqui-PREP (LGM-International, FL, USA), CellPrepPlus (Biodyne, Seongnam, Korea), Cell & Tech (Cell & Tech Bio, Seoul, Korea), EasyPrep (YD Diagnostics Corp., Seoul, Korea) and HuroPath (formerly known as E-Prep, CelltraZone, Seoul, Korea). The queries used were: '('Thyroid gland' (MeSH Term) OR 'Thyroid gland' (Text Word)) AND ('liquid-based preparation' (Text Word) OR 'liquid-based cytology' (Text Word) OR 'ThinPrep' (Text Word) OR 'SurePath' (Text Word) OR 'AutoCyte PREP' (Text Word) OR 'Liqui-Prep' (Text Word) OR 'CellPrepPlus' (Text Word) OR 'Cell & Tech' (Text Word) OR 'EasyPrep' (Text Word) OR 'E-Prep' (Text Word))' for PubMed, 'thyroid gland'/exp AND ('liquid-based preparation'/exp OR 'liquid based cytology' OR 'thinprep'/exp OR 'surepath'/exp OR 'autocyte prep'/exp OR 'liqui-prep'/exp OR 'cellprepplus'/exp OR 'cell & tech'/exp OR 'easyprep'/exp OR 'e-prep'/exp) for Embase, 'allintitle: thyroid AND ('thinprep' OR 'surepath' OR 'autocyte prep' OR 'liqui-prep' OR 'cellpreppro' OR 'cell & tech' OR 'easyprep' OR 'e-prep' OR 'liquid based preparation' OR 'liquid based cytology'' for Google Scholar. All similar possible word variations were also searched. The attained records were retrieved and managed with EndNote X7.2.1 (Bld 10136, Thomson Reuters, New York, NY, USA).

Study selection, reviewing and data retrieving
----------------------------------------------

The process of study selection and reviewing is depicted in [Fig. 1](#fig1){ref-type="fig"}. After the initial search, any duplicates were removed from the results. Then, the title and abstracts of the records were screened by two independent reviewers (Y Chong and E J Lee). Case reports, letters, reviews, conference proceedings and posters were excluded. Any original studies with cytohistological correlation data were included for full-text reviewing and only a subset of the studies with eligible data was used for quantitative analysis. In addition, the cited references in each study were manually searched and reviewed to identify any additional relevant studies. Figure 1Schematic illustration of the selection steps for reviewing candidate studies.

To apply the same standardized criteria for determining sensitivity and specificity, data from each study were retrieved and properly treated for quantitative analysis. Based on the treatment guidelines for thyroid lesions after FNAC, follicular neoplasms (FN) or Hurthle cell neoplasms (HCN) were considered to require surgical resection. Thus, we applied a tentative definition of positive, false positive, negative, and false negative solely based on the need for surgical resection. For example, FNAC results of FN or HCN with a histologic diagnosis of nodular hyperplasia (NH) or other benign lesions were tentatively considered as false-positive results, while the cases with histologic diagnosis of papillary carcinoma (PTC) were tentatively considered as positive results although the cytomorphologic features of FN/HCN and PTC are different. Likewise, FNAC results of atypia of undetermined significance (AUS) or benign follicular nodule with histologic diagnosis of FN or HCN were tentatively considered as false negative while the cases with NH or thyroiditis were tentatively considered as negative results. We hypothesized that the proportion of tentatively categorized false-positive or false-negative cases may be similar regardless of CS or LBP. Detailed interpretation criteria are shown in [Table 1](#tbl1){ref-type="table"}. Similar possible terminological variations among studies were recategorized into the relevant subcategories. Table 1Detailed tentative criteria for interpretation of FNAC results compared with histologic diagnosis.**InterpretationFNAC results of CS or LBPHistologic diagnosis**PositiveMalignancyPTCSuspicious for malignancyOther types of primary thyroidal malignancy including lymphomaFN (suspicious for)FA\*/FCHCN (suspicious for)HCA\*/HCCFalse positiveMalignancyNodular hyperplasia/colloid cystSuspicious for malignancyFN (suspicious for)Nodular hyperplasia/colloid cystHCN (suspicious for)NegativeBenign follicular noduleNodular hyperplasia/colloid cystAUS/FLUS\*Thyroiditis (Hashimoto's/lymphocytic/granulomatous)False negativeBenign follicular nodulePTCOther types of primary thyroidal malignancy including lymphomaBenign follicular noduleFA\*/FCHCA\*/HCC[^1]

Quality assessment of diagnostic accuracy studies
-------------------------------------------------

To assess the quality of the studies included in the meta-analysis, we incorporated the revised quality assessment of diagnostic accuracy studies, QUADAS-2, developed by Whiting *et al*. ([@bib3]). QUADAS-2 consists of four key domains: patient selection, index test, reference standard and flow and timing. A few signaling questions relevant to the risk of bias and the applicability in the index test domain were designed and added to the quality assessment as follows: Was a standardized classification system used? Was any risk of bias according to individual variation in the obtaining technique avoided? Was any risk of bias during data transformation and utilization avoided as much as possible?

Two independent reviewers (Y Chong and EJ Lee) reviewed the included studies using the modified QUADAS-2 and made a judgment on the risk of bias and the applicability of each domain. The results were tabulated and summarized after a discussion about the studies with discrepant assessments. The final meta-analysis was performed after the exclusion of any studies with a high risk of bias or concerns about bias in any of the domains.

Data extraction and analysis
----------------------------

The weighted average of sample inadequacy was calculated for each LBP method and CS. To determine the statistical significance, the weighted average difference was calculated in the studies that evaluated both LBP and CS using the same sample. A *P* value of less than 0.05 was defined as statistically significant. The reported sample inadequacy was categorized by the year of publication and compared by the mode of sampling method.

Results
=======

Study selection, reviewing and data retrieving
----------------------------------------------

The inclusion/exclusion process during the screening and selection steps is summarized in [Fig. 1](#fig1){ref-type="fig"}. A total of 372 papers were identified by the database search (81 in MEDLINE, 177 in EMBASE, 42 in Cochrane library and 72 in Google Scholar). After excluding 125 duplicates, a total of 247 records were screened by titles and abstracts. After 81 records were removed, 166 studies were subjected to further evaluation. Ninety-seven records of case reports, letters, reviews and conference proceedings were excluded, and only 51 studies were eligible for full-text reviewing (31 on TP, 12 on SP, 4 on Liqui-Prep, 1 on CellprepPlus, 1 on Cell & Tech, none on EasyPrep or E-prep). Among these, only 24 studies were eligible for data retrieval and qualitative synthesis (21 on TP, 6 on SP, 1 on Liqui-Prep, 1 on CellprepPlus, 1 on Cell & Tech, none on EasyPrep or E-prep).

Sample inadequacy of LBP
------------------------

The average sample inadequacy using all of the case data from the studies using either LBP alone, or LBP and CS or LBP and a combined method, are summarized in [Table 2](#tbl2){ref-type="table"} ([@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib20]). The average sample inadequacy in TP studies (17 studies, 24,880 cases) was 16.4% in the cases processed by TP, 33.4% by CS and 7.7% by a combined method ([Table 2A](#tbl2){ref-type="table"}). Average sample inadequacy in the SP studies (4 studies, 1706 cases) was 18.9% in the cases processed by SP, 12.6% by CS and 4.0% by a combined method ([Table 2B](#tbl2){ref-type="table"}) ([@bib21], [@bib22], [@bib23], [@bib24]). Only one study each was included for calculating average sample inadequacy for Liqui-PREP ([@bib25]), CellprepPlus ([@bib26]) and the Cell and Tech method ([@bib27]) ([Table 2C](#tbl2){ref-type="table"}, [D](#tbl2){ref-type="table"} and [E](#tbl2){ref-type="table"}). Table 2Reported sample adequacy (weighted average) of the studies using a LBP and a CS/combined method.**YearAuthorsTotal casesInadequacy** (case number/%)Sampling methodTPCSTP + CS(A) ThinPrep vs conventional smear2000Scurry *et al*. ([@bib4])72840140.932750.5----Direct to vial2001Afify *et al*. ([@bib5])2098211.012720.5----Syringe rinsing2001Nasuti *et al*. ([@bib6])663327.3----3315.2Consultation slide2003Cochand-Priollet *et al*. ([@bib7])24012022.51208.3----Splitting2004Tulecke *et al*. ([@bib8])1151156.1--------Direct to vial2006Fadda *et al*. ([@bib9])2006200611.3--------Direct to vial2006Malle *et al*. ([@bib10])7444593.92858.9----Syringe rinsing2007Michael *et al*. ([@bib11])21821833.0--------Direct to vial2008Cavaliere *et al*. ([@bib12])7750387532.3387536.5----Double sampling2008Saleh *et al*. ([@bib13])29014524.114537.2----Syringe rinsing2008Stamataki *et al*. ([@bib14])2522524.0--------Direct to vial2010Ardito *et al*. ([@bib15])353--------3531.1Syringe rinsing2011Gheri *et al*. ([@bib16])251825189.4--------Direct to vial2011Luu *et al*. ([@bib17])410121018.2----20008.7Syringe rinsing2012Chang *et al*. ([@bib18])4290252312.6176725.9----Direct to vial2013Mastorakis *et al*. ([@bib19])100010004.1--------Direct to vialTotal24,48015,84816.4664633.423867.7**YearAuthorsTotal casesInadequacy** (case number/%)**Sampling method**SPCSSP + CS(B) SurePath vs conventional smear2007Kim *et al*. ([@bib21])3441729.317220.9----Direct to vial2008Jung *et al*. ([@bib22])3861935.21936.2----Syringe rinsing2009Sidiropoulos *et al*. ([@bib23])264----12111.01434.0Syringe rinsing2011Geers *et al*. ([@bib24])71271225.0--------Direct to vialTotal1706107718.948612.61434.0**YearAuthorsTotal casesInadequacy** (case number/%)**Sampling method**LPCSLP + CS(C) Liqui-PREP vs conventional smear2012Tetikkurt *et al*. ([@bib25])3781894.21894.2Double samplingTotal3781894.21894.2**YearAuthorsTotal casesInadequacy** (case number/%)**Sampling method**CPCSCP + CS(D) CellprepPlus vs conventional smear2011Koo *et al*. ([@bib26])39619848.519816.2Double samplingTotal39619848.519816.2**YearAuthorsTotal casesInadequacy** (case number/%)**Sampling method**CTCSCT + CS(E) Cell and Tech vs conventional smear2013Lee *et al*. ([@bib27])1537022.9831.2splittingTotal1537022.9831.2[^2]

Sample inadequacy using the case data of the comparative studies of LBP and CS is summarized in [Table 3](#tbl3){ref-type="table"} ([@bib4], [@bib5], [@bib7], [@bib10], [@bib12], [@bib13], [@bib18]). Average sample inadequacy in TP studies (7 studies, 14,251 cases) was significantly lower in TP (24.0%) than CS (33.4%) (*P* \< 0.01). Likewise, average sample inadequacy in SP studies (2 studies, 730 cases) was significantly lower in SP (7.1%) than CS (13.2%) (*P* \< 0.02), although the number of included studies was limited. Table 3Difference in sample inadequacy between LBP and CS (weighted average difference).**YearAuthorsTotal casesInadequacy** (case number/%)**Sampling method**TPCS(A) ThinPrep vs CS2000Scurry *et al*. ([@bib4])72840140.932750.5Direct to vial2001Afify *et al*. ([@bib5])2098211.012720.5Syringe rinsing2003Cochand-Priollet *et al*. ([@bib7])24012022.51208.3Splitting2006Malle *et al*. ([@bib10])7444593.92858.9Syringe rinsing2008Cavaliere *et al*. ([@bib12])7750387532.3387536.5Double sampling2008Saleh *et al*. ([@bib13])29014524.114537.2Syringe rinsing2012Chang *et al*. ([@bib18])4290252312.6176725.9Direct to vialTotal14,251760524.0664633.4*P* \< 0.01**YearAuthorsTotal casesInadequacy** (case number/%)**Sampling method**SPCS(B) SurePath vs CS2007Kim *et al*. ([@bib21])3441729.317220.9Direct to vial2008Jung *et al*. ([@bib22])3861935.21936.2Syringe rinsingTotal7303657.136513.2*P* \< 0.02[^3][^4]

Sample inadequacy of TP studies gradually decreased from the first dates of publication to the more recent ones and the inadequacy trend line of TP was slightly lower than that of CS ([Fig. 2A](#fig2){ref-type="fig"}). The accumulated inadequacy of TP studies more clearly demonstrates this finding ([Fig. 2B](#fig2){ref-type="fig"}). Sample inadequacy was significantly lower by TP than CS in samples collected by double sampling or syringe rinsing or directly collected to vial from the different patients (during the different periods) ([Fig. 2C](#fig2){ref-type="fig"}). However, sample inadequacy was significantly higher in TP than CS in the consultation slide or the samples collected by splitting ([Fig. 2C](#fig2){ref-type="fig"}). Figure 2Sample inadequacy rate of TP and CS. Trends of reported inadequacy (A) and accumulated inadequacy (B) of TP and CS of thyroid samples by year, sample inadequacy rate by various sampling methods (C). CS, conventional smear; TP, ThinPrep.

Sensitivity and specificity of LBP
----------------------------------

A coupled forest plot of sensitivity and specificity of 17 TP studies is shown in [Fig. 3A](#fig3){ref-type="fig"} ([@bib4], [@bib5], [@bib7], [@bib8], [@bib9], [@bib11], [@bib12], [@bib4], [@bib5], [@bib16], [@bib7], [@bib8], [@bib9], [@bib20], [@bib8], [@bib9], [@bib30], [@bib31]). There was no obvious relationship between sensitivity and specificity among 17 studies using TP. Sensitivity and specificity of CS showed more homogeneous results than those of TP because TP data in some studies were limited by sample type and data quality ([Fig. 3A](#fig3){ref-type="fig"}). A forest plot of the combined TP and CS studies showed heterogeneity because of the limited number of included studies and the limited data quality of the included studies ([Fig. 3C](#fig3){ref-type="fig"}) (*Q* value). The sROC using these data showed similar curves between TP and CS; more precisely, a slightly higher curve for TP, showing a significant difference in specificity and sensitivity between TP and CS in thyroid FNAC ([Fig. 3D](#fig3){ref-type="fig"}). Although the sROC of the combined TP and CS was lower than the others, it should be interpreted with caution because it was based on data derived from a limited number of studies. Figure 3Coupled forest plots of the studies using TP (A), CS (B) and combined TP and CS (C), and a corresponding sROC (D). CS, conventional smear; sROC, synthesized reporter operating curve; TP, ThinPrep.

A forest plot of TP after exclusion of studies of limited quality showed more homogenous results ([Fig. 4A](#fig4){ref-type="fig"}) ([@bib4], [@bib5], [@bib7], [@bib9], [@bib11], [@bib12], [@bib4], [@bib5], [@bib18], [@bib9], [@bib20], [@bib31]). The heterogeneity of studies of TP and CS was similar (based on the *Q* value). Only one study was included in this analysis for combined TP and CS ([Fig. 4C](#fig4){ref-type="fig"}). The sROC derived from these studies showed similar but slightly higher curves for TP than the previous sROC ([Fig. 4D](#fig4){ref-type="fig"}). Figure 4Coupled forest plots after exclusion of limited studies using TP (A), CS (B) and combined TP and CS (C), and a corresponding sROC (D). CS, conventional smear; sROC, synthesized reporter operating curve; TP, ThinPrep.

For SP, a forest plot drawn from SP and CS is depicted in [Fig. 5A](#fig5){ref-type="fig"} and [B](#fig5){ref-type="fig"}, and it showed moderate heterogeneity (*Q* value) ([@bib21], [@bib22], [@bib24], [@bib32], [@bib33]). A sROC using 5 SP studies and 3 CS studies showed curves with similar sensitivity and specificity ([Fig. 5C](#fig5){ref-type="fig"}). Figure 5Coupled forest plots after exclusion of limited studies using SP (A), CS (B) and a corresponding sROC (C). CS, conventional smear; SP, SurePath; sROC, synthesized reporter operating curve.

Quality assessment of diagnostic accuracy studies
-------------------------------------------------

Quality assessments of the included studies are summarized in [Table 4](#tbl4){ref-type="table"} and [Supplementary Fig. 1](http://www.endocrineconnections.org/cgi/content/full/EC-17-0165/DC1) (see section on [supplementary data](#supp1){ref-type="supplementary-material"} given at the end of this article). Most studies in the final meta-analysis had a low risk of bias or concern in each domain according to risk of bias or applicability, which represents a relatively high level of credibility in the results of the meta-analysis. Three studies showed an uncertain risk of bias or concern in one domain among the TP studies. Only one study among SP studies showed uncertain concern in the applicability during the patient selection. Table 4Results of QUADAS-2 of the studies included in the final meta-analysis.**Risk of biasApplicability concerns**Patient selectionIndex testReference standardFlowing and timingPatient selectionIndex testReference standardTP studies 1995 Biscotti *et al*. ([@bib31])LLLLLLL 2001 Afify *et al*. ([@bib5])L?LLLLL 2003 Cochand-Priollet *et al*. ([@bib7])LLLLLLL 2006 Fadda *et al*. ([@bib9])LLLLLLL 2007 Michael *et al*. ([@bib11])LLLLLLL 2008 Cavaliere *et al*. ([@bib12])LLLLLLL 2008 Stamataki *et al*. ([@bib14])LLLLLLL 2010 Ardito *et al*. ([@bib15])LLLLLLL 2012 Chang *et al*. ([@bib18])LLLLLLL 2014 Mastorakis *et al*. ([@bib19])LL?LLLLSP studies 2007 Kim *et al*. ([@bib21])LLLLLLL 2008 Jung *et al*. ([@bib22])LLLLLLL 2011 Geers *et al*. ([@bib24])LLLLLLL 2011 Kim *et al*. ([@bib33])LLLL?LL 2013 Lee *et al*. ([@bib32])LLLLLLL[^5]

Morphologic characteristics of LBP
----------------------------------

Morphologic parameters could not be compared using meta-analysis because each study applied a customized strategy that could not be easily standardized for meta-analysis. Major morphologic characteristics of each LBP compared to CS described by a few key studies are summarized in [Table 5](#tbl5){ref-type="table"} ([@bib8], [@bib8], [@bib27], [@bib8], [@bib29], [@bib34], [@bib35]). Table 5Major morphologic characteristics of liquid-based preparation compared to conventional smear reported in the literature.**YearAuthorsLBP methodMorphologic characteristics**2001Zhang *et al*. ([@bib28])TPIntranuclear inclusion, papillary and/or sheet arrangements, nuclear grooves, powdery chromatin and nuclear molding are the most powerful features in LBP for differential diagnosis of PTC from others2003Cochand-Priollet *et al*. ([@bib7])TPThe colloids often occur in small dense droplets rather than in a film. Nuclei tend to appear smaller but the nuclear details, especially the nuclear membrane, the chromatin and the nucleoli are more easily observed. In cases of PTC on TP slides, nuclear cytoplasmic inclusions are rare but nuclear grooves and ground-glass nuclei are frequently observed. Oncocytic cells have a pale cytoplasm mostly lacking blue granules on TP. The diagnosis of Hashimoto's thyroiditis is more difficult on TP slides than on CS because of the limited number of lymphocytes2004Tulecke *et al*. ([@bib8])TPLarge colloid fragments, tissue paper-like material, cystic change and monolayered sheets of follicular cells in LBP are associated with macrofollicular or mixed architecture on histology2010Chae *et al*. ([@bib34])SPLBP showed higher cellularity, better 3D configuration, more follicle patterns and dispersed single cells2012Chang *et al*. ([@bib18])TPLBP showed better preserved nuclear details, a cleaner background and fewer large papillae than CS2012Tetikkurt *et al*. ([@bib25])Liqui-PREPThe most important and specific features for papillary carcinoma are the presence of intranuclear inclusions and grooves. Nuclear irregularity is the crucial hallmark for the differentiation of follicular neoplasm and malignant lesions. The presence of nucleoli and regular nucleus may appear as other outstanding features for the diagnosis of follicular neoplasm2013Chung *et al*. ([@bib35])SPHobnail features in papillary carcinoma are often associated with cytoplasmic vacuole, background macrophages and lymph node metastasis2013Rossi *et al*. ([@bib29])TPLarge oncocytic cells with a discohesive pattern are more common in malignant oncocytic/Hurthle cell neoplasms2013Lee *et al*. ([@bib27])Cell & TechNuclear grooves and intranuclear inclusions are difficult to visualize on LBP2016Chong *et al*. ([@bib36])EasyPrepCompared to SP, EasyPrep allows easier fragmentation of the cell clusters, producing more 2-dimensional sheet-like clusters in benign cases, and clearer visibility for nuclear features of PTCs. The nuclear size is smaller on SP, which makes nuclear irregularity and grooves more evident. However, intranuclear inclusions are less obvious. Incompletely lysed red blood cells are more prominent in EasyPrep[^6]

Discussion
==========

This study demonstrated that the clinical utility of LBP is almost the same or marginally better than that of CS for thyroid FNAC in terms of sample adequacy, sensitivity and specificity.

Sample inadequacy of LBP
------------------------

The sample adequacy was significantly superior for two mainstream LBP methods (ThinPrep and SurePath) than CS for most sampling methods ([Table 3](#tbl3){ref-type="table"}). More data on sample adequacy are needed for the newly developed techniques such as Liqui-PREP, CellprepPlus and the Cell and Tech method ([Table 2](#tbl2){ref-type="table"}). We can see clearly that the sample adequacy is getting better over time after the introduction of LBP for thyroid FNAC ([Fig. 2A](#fig2){ref-type="fig"} and [B](#fig2){ref-type="fig"}). This must be due to a learning curve of the new technology. This trend suggests that the learning curve has reached a stage of maturity for the new technology.

As expected, sample adequacy was better for LBP (TP) than CS using sampling methods where relatively equal amounts of sample content might be distributed to LBP and CS, such as double sampling, direct to vial (different samples), and syringe rinsing methods. Sample adequacy using consultation slides and sample splitting methods showed better adequacy for CS than TP. This can be explained by the fact that most consultation slides contain samples from the primary screening laboratory that might contain generally lower cellularity. Sample splitting is a limited method inevitably producing disproportionate samples used for LBP and CS, as many prior studies have shown. Combined LBP and CS methods showed much lower rates of sample inadequacy than LBP or CS alone for both TP and SP studies, although the difference was not statistically significant ([Table 2](#tbl2){ref-type="table"}).

Sensitivity and specificity of LBP
----------------------------------

The sensitivity and specificity of LBP over CS using sROC showed similar or slightly better results for TP than CS ([Fig. 3](#fig3){ref-type="fig"}). The results were clearer after the exclusion of studies with poor or limited data quality ([Fig. 4](#fig4){ref-type="fig"}). The results were similar for SP studies as well ([Fig. 5](#fig5){ref-type="fig"}). For SP studies, there is a generalizability limitation because the included studies are all from either Belgium or South Korea.

On a side note to the results of meta-analysis, there were two studies that deal with cytohistological correlation data of other LBPs, one for CellprepPlus and one for EasyPrep ([@bib26], [@bib36]). The CellprepPlus study compared only 20 cases of CellprepPlus and CS, but it showed 100% sensitivity and specificity for CS and 71.4% sensitivity and 86.7% negative predictive value for CellprepPlus for the histologic correlation (data not shown) ([@bib26]). The EasyPrep study compared only 28 and 26 cases of SP and EasyPrep and histologic diagnosis and showed 100% sensitivity and specificity for SP and 95.5% sensitivity and 80% negative predictive value for EasyPrep ([@bib36]).

Morphologic characteristics of LBP
----------------------------------

The morphologic parameters were not feasible for meta-analytic comparison because it is generally thought that the standards of morphologic parameters vary widely among various sampling methods, LBP methods, study designs and investigators. However, we can summarize the general morphologic changes of LBP in thyroid FNAC compared to CS based on the consistent findings of most studies. In LBP, the nuclear size is smaller, the nuclear-to-cytoplasmic ratio is bigger, nucleoli are more prominent and nuclear membrane irregularity and nuclear grooves become more obvious. The cytoplasm is scantier in LBP. These changes are probably due to a lack of the smearing effect that can be a potential cause of dry or degenerative artifacts in CS. However, intranuclear pseudoinclusions are less evident on LBP than CS owing to the ingredient changes in the fixative solutions of LBP. Increases of 3-dimensional clusters and decreases of large papillae by fragmentation are other important features of LBP compared to CS. These can be understood to be a result of the homogenizing step of LBP. Therefore, LBP gives better cytomorphologic visibility for follicular clusters of the benign lesions while it loses the important papillary structure of PTCs. For follicular lesions, macrofollicular architecture, Hurthle cell changes and the presence of colloid (tissue-paper-like material) and macrophages serve as important features to suspect benign follicular lesions, which is similar in CS ([@bib8]).

Quality assessment of diagnostic accuracy studies
-------------------------------------------------

QUADAS-2 assessment of the included studies revealed that only a few studies had an uncertain risk of bias or concern in one domain, which means that the results of this meta-analysis are trustworthy. Furthermore, the results of the sROC curve before and after the exclusion of the studies with limited quality were consistent. From the beginning, we hypothesized that the simplified, tentative categorization of the cytopathological diagnosis into four groups according to the consequent surgical treatment plan ([Table 1](#tbl1){ref-type="table"}), true and false positive, or true and false negative, might not influence the results of the meta-analysis mathematically. However, there should be caution when applying the results of this study under some circumstances.

Conclusion
==========

Based on the results of this study, we conclude that it is reasonable for LBP to be substituted for CS of FNAC of thyroid lesions for the following reasons. First, the sample adequacy is statistically superior for LBP than CS. Second, the sensitivity and specificity of LBP was similar or slightly superior to that of CS. Third, although an educational period is essential and there are pros and cons of cytomorphologic features using LBP in thyroid FNAC, it does not seem to greatly affect the accuracy of the diagnosis itself. Therefore, it is okay to trust the results of any of the two major LBPs (TP and SP) for thyroid FNAC, even when it is performed alone without additional CS. However, additional data and further evaluation are needed for the other LBPs to confirm their results.
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[^1]: AUS, atypia of undetermined significance; FA, follicular adenoma; FC, follicular carcinoma; FLUS, follicular lesion of undetermined significance; HCA, Hurthle cell adenoma; HCC, Hurthle cell carcinoma; PTC, papillary thyroid carcinoma.

[^2]: CP, CellprepPlus; CS, conventional smear; LBP, liquid-based preparation; LP, Liqui-PREP; TP, ThinPrep; SP, SurePath.

[^3]: \(A\) TP vs CS, (B) SP vs CS.

[^4]: CS, conventional smear; LBP, liquid-based preparation; SP, SurePath; TP, ThinPrep.

[^5]: L, low risk; H, high risk; ?, unclear risk; QUADAS-2, revised quality assessment of diagnostic accuracy studies; SP, SurePath; TP, ThinPrep.

[^6]: CS, conventional smear; LBP, liquid-based preparation; PTC, papillary thyroid carcinoma; SP, SurePath; TP, ThinPrep.
